Amniotics AB (publ) (STO:AMNI)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0054
+0.0003 (5.88%)
Inactive · Last trade price on Sep 27, 2024
5.88%
Market Cap14.76M
Revenue (ttm)2.45M
Net Income (ttm)-20.19M
Shares Out2.73B
EPS (ttm)-0.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,955,130
Average Volume2,395,968
Open0.0054
Previous Close0.0051
Day's Range0.0052 - 0.0054
52-Week Range0.0012 - 0.0456
Beta0.53
RSI57.97
Earnings DateFeb 18, 2025

About Amniotics AB

Amniotics AB (publ) develops, manufactures, and sells stem cell therapies based on mesenchymal stem cells to treat severe life-threatening diseases. The company's lead drug candidate is PulmoStem for the treatment of inflammatory and fibrotic lung disease. It also develops CogniStem for the treatment of CNS indications; NephroStem for the treatment of kidney-specific indications; and CutiStem for the treatment of dermatological indications. The company offers contract development and contract manufacturing services for advanced therapy medicina... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 6
Stock Exchange Nasdaq Stockholm
Ticker Symbol AMNI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.